Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Kay

Showing results (241-250 of 325) with videos related to

Pageof 33
Sort By:
Blood|January 9, 2024
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signatureSalma B Abdelbaky, Brian Giacopelli, Kari G Rabe, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric studyMingfei Yan, Sameer A Parikh, Michelly K Sampaio De Melo, et al.
Annals of Hematology|June 4, 2020
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomesWilliam J Archibald, Kari G Rabe, Brian F Kabat, et al.
Blood|November 15, 2008
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximabFarrukh T Awan, Neil E Kay, Melanie E Davis, et al.
Cancer Research|April 5, 2017
Precancer Atlas to Drive Precision Prevention TrialsAvrum Spira, Matthew B Yurgelun, Ludmil Alexandrov, et al.
Leukemia|May 5, 2023
Relationship among three common hematological premalignant conditionsNicholas J Boddicker, Sameer A Parikh, Aaron D Norman, et al.
Hematological Oncology|November 22, 2021
Differential transcriptomic profiling in ibrutinib-naïve versus ibrutinib-resistant Richter syndromeHanyin Wang, Shulan Tian, Qing Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemiaRainer Claus, David M Lucas, Stephan Stilgenbauer, et al.
Leukemia & Lymphoma|November 9, 2016
Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practiceHeidi D Finnes, Kari G Chaffee, Timothy G Call, et al.
British Journal of Haematology|August 18, 2018
Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centrePaul J Hampel, Melissa C Larson, Brian Kabat, et al.
Pageof 33

Showing results (241-250 of 325) with videos related to

Sort By:
Pageof 33
Blood|January 9, 2024
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signatureSalma B Abdelbaky, Brian Giacopelli, Kari G Rabe, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric studyMingfei Yan, Sameer A Parikh, Michelly K Sampaio De Melo, et al.
Annals of Hematology|June 4, 2020
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomesWilliam J Archibald, Kari G Rabe, Brian F Kabat, et al.
Blood|November 15, 2008
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximabFarrukh T Awan, Neil E Kay, Melanie E Davis, et al.
Cancer Research|April 5, 2017
Precancer Atlas to Drive Precision Prevention TrialsAvrum Spira, Matthew B Yurgelun, Ludmil Alexandrov, et al.
Leukemia|May 5, 2023
Relationship among three common hematological premalignant conditionsNicholas J Boddicker, Sameer A Parikh, Aaron D Norman, et al.
Hematological Oncology|November 22, 2021
Differential transcriptomic profiling in ibrutinib-naïve versus ibrutinib-resistant Richter syndromeHanyin Wang, Shulan Tian, Qing Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemiaRainer Claus, David M Lucas, Stephan Stilgenbauer, et al.
Leukemia & Lymphoma|November 9, 2016
Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practiceHeidi D Finnes, Kari G Chaffee, Timothy G Call, et al.
British Journal of Haematology|August 18, 2018
Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centrePaul J Hampel, Melissa C Larson, Brian Kabat, et al.
Pageof 33